Home › Products › Infectious Disease › Lamistar 30 Tablet
Lamistar 30 Tablet
Salt Composition: LAMIVUDINE,STAVUDINE
- Manufacturer: HETERO HEALTHCARE LTD
- Pack Size: 60 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Prescription Required
- Storage: Store in a cool, dry place below 25°C, away from light and moisture. Do not skip doses. If you miss one, take it as soon as you remember. If itâs close to the next dose, skip the missed one. Do not double-dose to make up for a missed one. In case of overdose, seek immediate medical help even if there are no symptoms.
₹532.00₹664.22
Inclusive of all taxes
Product Introduction
Lamistar 30 Tablet is a prescription antiretroviral medicine indicated for treatment of Human Immunodeficiency Virus (HIV) infection. It contains Lamivudine and Stavudine, two nucleoside reverse transcriptase inhibitors (NRTIs) that work synergistically to reduce viral load and strengthen immune function in patients with HIV. This combination is employed as part of Highly Active Antiretroviral Therapy (HAART) and does not cure HIV or AIDS. It serves to manage infection, enhance quality of life, and lower the risk of complications. Strict adherence to prescribed dosing is essential, and discontinuation should not occur without medical consultation. Lamistar 30 mg Tablet requires cautious use in patients with hepatic impairment or prior history of pancreatitis. Use during pregnancy is not advised unless specifically directed by a doctor. Concurrent alcohol consumption and other medicines may elevate the risk of adverse effects. Full medical history should be disclosed to the prescribing doctor, and treatment guidance must be followed as directed.
Uses
Lamistar 30 Tablet is FDA-approved for the following use: Treatment of HIV-1 infection in adults and pediatric patients in combination with other antiretroviral agents.
How it works
This medicine works by blocking a special enzyme called reverse transcriptase, which the HIV virus needs to make copies of itself. When the virus canât make more copies, it slows down its growth in the body. Over time, this helps lower the viral load and gives the immune system a chance to recover and work better. Taking this medicine consistently as prescribed helps reduce the risk of HIV-related complications and may also reduce the chances of transmitting the virus to others. However, it is not a standalone treatment and must be taken with other HIV medicines.
How to Use
Lamistar 30 Tablet is available in tablet or capsule form. It is usually taken orally twice a day, with or without food. Swallow it whole with water and avoid crushing or chewing the tablet unless advised by a healthcare provider. For best results, take the medicine at the same time each day to maintain a consistent level in your body.
Side Effects
Common side effects: Headache Nausea or vomiting Tiredness or fatigue Diarrhea Peripheral neuropathy (tingling or numbness in hands or feet) Fever or chills Serious side effects (seek immediate medical help): Lactic acidosis (deep rapid breathing, stomach pain, muscle weakness) Severe liver problems (yellowing of skin/eyes, dark urine) Pancreatitis (severe stomach pain, nausea) Muscle weakness or loss of muscle Allergic reactions (rash, itching, swelling)
Expert Tips
Do not stop taking Lamistar 30 Tablet without consulting your doctor, even if you feel better. Skipping doses can lead to viral resistance, making treatment less effective. Keep regular follow-up appointments to monitor your blood counts, liver function, and signs of side effects. Inform your doctor about any numbness, muscle pain, or unusual fatigue. Always practice safe sex and avoid sharing personal items like razors or toothbrushes.
References
- https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/022085PI.pdf
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020564s37_020596s036lbl.pdf
Safety Advice
Pregnancy: Consult your doctor Lamistar 30 Tablet is not recommended during pregnancy unless absolutely necessary and prescribed by your doctor, as it may harm the unborn baby.
Lungs: safe Lamistar 30 Tablet generally does not affect the lungs directly but any shortness of breath or cough should be reported, especially if persistent.
Breastfeeding: unsafe Lamistar 30 Tablet should not be used during breastfeeding as the medicine can pass into breast milk and may harm the baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.